Literature DB >> 19801508

Cutting Edge: Importance of IL-6 and cooperation between innate and adaptive immune receptors in cellular vaccination with B lymphocytes.

Tony J Vanden Bush1, Claire M Buchta, Jennifer Claudio, Gail A Bishop.   

Abstract

B lymphocytes are a potential alternative to dendritic cell immunotherapy, with the advantages of relative abundance in peripheral blood and the ability to function as APCs. Although B cells express multiple receptors that induce costimulatory molecules, B cell vaccine studies have focused primarily on CD40 stimulation. To optimize the potential efficacy of B cell vaccines (Bvac), we compared the capacity of differentially stimulated B cells to induce Ag-specific CD8(+) T cell responses in vivo. CD40- or TLR7-stimulated B cell APCs induced similar CD8(+) T cell responses, but costimulation through the BCR and TLR7 produced a more effective Bvac as measured by T cell stimulation and the protection of mice from an infectious pathogen. This increased effectiveness depended upon enhanced production of IL-6 by BCR plus TLR7-stimulated B cells. These findings reveal alternative stimulation strategies for the production of effective Bvac and identify a key role for IL-6 in B cell Ag presentation and cellular vaccines.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19801508     DOI: 10.4049/jimmunol.0900968

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  14 in total

Review 1.  Roles of tumor necrosis factor receptor associated factor 3 (TRAF3) and TRAF5 in immune cell functions.

Authors:  Joanne M Hildebrand; Zuoan Yi; Claire M Buchta; Jayakumar Poovassery; Laura L Stunz; Gail A Bishop
Journal:  Immunol Rev       Date:  2011-11       Impact factor: 12.988

Review 2.  Toll-like receptors and B cells: functions and mechanisms.

Authors:  Claire M Buchta; Gail A Bishop
Journal:  Immunol Res       Date:  2014-08       Impact factor: 2.829

3.  Adoptive transfer of tumor reactive B cells confers host T-cell immunity and tumor regression.

Authors:  Qiao Li; Xiangming Lao; Qin Pan; Ning Ning; Ji Yet; Yingxin Xu; Shengping Li; Alfred E Chang
Journal:  Clin Cancer Res       Date:  2011-06-20       Impact factor: 12.531

4.  IL-6 promotes cardiac graft rejection mediated by CD4+ cells.

Authors:  Adam Jared Booth; Svetlana Grabauskiene; Sherri Chan Wood; Guanyi Lu; Bryna E Burrell; D Keith Bishop
Journal:  J Immunol       Date:  2011-10-24       Impact factor: 5.422

5.  Nanoemulsion mucosal adjuvant uniquely activates cytokine production by nasal ciliated epithelium and induces dendritic cell trafficking.

Authors:  Paul E Makidon; Igor M Belyakov; Luz P Blanco; Katarzyna W Janczak; Jeffrey Landers; Anna U Bielinska; Jeffrey V Groom; James R Baker
Journal:  Eur J Immunol       Date:  2012-07-04       Impact factor: 5.532

6.  Targeting of antigens to B lymphocytes via CD19 as a means for tumor vaccine development.

Authors:  Yunfeng Ma; Dong Xiang; Jinwen Sun; Chuanlin Ding; Min Liu; Xiaoling Hu; Guoxin Li; Goetz Kloecker; Huang-Ge Zhang; Jun Yan
Journal:  J Immunol       Date:  2013-04-29       Impact factor: 5.422

7.  Rotavirus differentially infects and polyclonally stimulates human B cells depending on their differentiation state and tissue of origin.

Authors:  Carlos F Narváez; Manuel A Franco; Juana Angel; John M Morton; Harry B Greenberg
Journal:  J Virol       Date:  2010-02-17       Impact factor: 5.103

8.  Chronic heat stress weakened the innate immunity and increased the virulence of highly pathogenic avian influenza virus H5N1 in mice.

Authors:  Yi Jin; Yanxin Hu; Deping Han; Ming Wang
Journal:  J Biomed Biotechnol       Date:  2011-05-29

9.  CD40-activated B cells can efficiently prime antigen-specific naïve CD8+ T cells to generate effector but not memory T cells.

Authors:  Mélissa Mathieu; Natacha Cotta-Grand; Jean-François Daudelin; Salix Boulet; Réjean Lapointe; Nathalie Labrecque
Journal:  PLoS One       Date:  2012-01-23       Impact factor: 3.240

10.  IL-6 production by dendritic cells is dispensable for CD8+ memory T-cell generation.

Authors:  Jean-François Daudelin; Mélissa Mathieu; Salix Boulet; Nathalie Labrecque
Journal:  Biomed Res Int       Date:  2012-12-30       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.